Preventive Human Papillomavirus (HPV) Vaccine Trial in Kidney Transplant Recipients

NCT03036930 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

51

Enrollment

NIH

Sponsor class

Conditions

Human Papillomavirus Infection
Human Papillomavirus-Related Carcinoma

Interventions

PROCEDURE: Biospecimen Collection
PROCEDURE: HPV Self-Collection
OTHER: Questionnaire Administration
BIOLOGICAL: Recombinant Human Papillomavirus Nonavalent Vaccine

Sponsor

National Cancer Institute (NCI)